Bill Maughan's Stock Ratings

Canaccord Genuity Analyst

Bill Maughan is an analyst at Canaccord Genuity. Analyst ratings are quantitative and qualitative analysis of a stock by Wall Street stock rating analysts. Stock ratings consist of expected future growth, current stock valuation and macroeconomic trends. Updated 06/16/2025

Overall Average Return

-44.6%

Smart Score

19.2%

Overall Average Return Percentile

3rd

Number of Ratings

14
Buy NowGet Alert
08/13/2024YMABBuy Now
Y-mAbs Therapeutics
$4.71452.02%
Bill Maughan19%
$26 → $26MaintainsBuyGet Alert
05/10/2024NKTXBuy Now
Nkarta
$1.90689.47%
Bill Maughan19%
$16 → $15MaintainsBuyGet Alert
05/10/2024FATEBuy Now
Fate Therapeutics
$1.32581.82%
Bill Maughan19%
$11 → $9MaintainsBuyGet Alert
05/09/2024IMCRBuy Now
Immunocore Hldgs
$34.6893.19%
Bill Maughan19%
$63 → $67MaintainsHoldGet Alert
05/03/2024MRNABuy Now
Moderna
$26.76296.11%
Bill Maughan19%
$91 → $106MaintainsHoldGet Alert
03/26/2024NKTXBuy Now
Nkarta
$1.90742.11%
Bill Maughan19%
$15 → $16MaintainsBuyGet Alert
03/15/2024IPSCBuy Now
Century Therapeutics
$0.603888.04%
Bill Maughan19%
$22 → $24MaintainsBuyGet Alert
03/04/2024YMABBuy Now
Y-mAbs Therapeutics
$4.71452.02%
Bill Maughan19%
$22 → $26MaintainsBuyGet Alert
02/29/2024IMCRBuy Now
Immunocore Hldgs
$34.6881.66%
Bill Maughan19%
$60 → $63MaintainsHoldGet Alert
02/23/2024MRNABuy Now
Moderna
$26.76240.06%
Bill Maughan19%
$82 → $91MaintainsHoldGet Alert
02/21/2024BCYCBuy Now
Bicycle Therapeutics
$8.37616.85%
Bill Maughan19%
→ $60ReiteratesBuy → BuyGet Alert
11/29/2023MRNABuy Now
Moderna
$26.76206.43%
Bill Maughan19%
→ $82Initiates → HoldGet Alert
11/02/2023MRUSBuy Now
Merus
$54.61-17.6%
Bill Maughan19%
→ $45Initiates → BuyGet Alert
07/17/2023IMCRBuy Now
Immunocore Hldgs
$34.6893.19%
Bill Maughan19%
→ $67Initiates → HoldGet Alert